The MFDS plays a key role in approving generic drugs by evaluating their bioequivalence to reference products, ensuring the same safety, efficacy, and quality standards. It reviews detailed data on formulation, manufacturing processes, and clinical studies before granting approval, enabling safe and effective alternatives to branded drugs.
